Other functions atlanta biologicals INC:1109260 [13-001801]

Ended Awarded

Contract number
HHSN26100006
Awardee
Awarding agency
Obligated
$7,544

Award facts

Contract value 100% obligated
$7,544.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325414 Biological Product (except Diagnostic) Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Lawrenceville, GA 30043, USA

Award details come from SAM.gov/FPDS.

About this award

This is a firm fixed-price contract awarded by the National Cancer Institute, a civilian agency within the U.S. government, to Atlanta Biologicals Incorporated. The contract has a ceiling value of $7,544 and an ultimate completion date of March 27, 2013. The contract type is a BPA (Blanket Purchase Agreement) Call, which suggests it is part of a larger contracting vehicle. The contract is for "OTHER FUNCTIONS ATLANTA BIOLOGICALS INC:1109260 [13-001801]" but no further details are provided about the specific products or services being delivered. The contract does not have a set-aside designation.

Quick answers

Who was awarded contract HHSN26100006?

HHSN26100006 was awarded to Atlanta Biologicals Incorporated by National Cancer Institute (National Institutes of Health) on October 26, 2012.

How much is contract HHSN26100006 worth?

The government has obligated $7,544 on HHSN26100006.

Is contract HHSN26100006 an order under another contract?

Yes. HHSN26100006 is a BPA call under HHSN263200600063475B, a blanket purchase agreement.

Was contract HHSN26100006 competed?

The extent of competition for HHSN26100006 was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award